Skip to main content
SpringerLink
Log in

Alternative Impfstofferzeugung

Quadrivalentes Influenzavakzin aus Zellkultur schützt Minderjährige gut

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Wu NC, Zost SJ, Thompson AJ et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 2017;13(10):e1006682

  2. Hartvickson R, Cruz M, Ervin J et al. Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multi-center, double-blind clinical trial. Int J Infect Dis. 2015;41:65-72

  3. Bruxvoort KJ, Luo Y, Ackerson B et al. Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. Vaccine. 2019;37:5807-11

Download references

Author information

Authors and Affiliations

  1. Klinikum am Steinenberg/Ermstalklinik, Med. Klinik III/Innere Medizin/Pneumologie, Stuttgarter Str. 100, 72574, Reutlingen/Bad Urach, Deutschland

    Adrian Gillissen

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Quadrivalentes Influenzavakzin aus Zellkultur schützt Minderjährige gut. Pneumo News 13, 22–23 (2021). https://doi.org/10.1007/s15033-021-2782-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2782-0

Search

Navigation